0001209191-21-028565.txt : 20210427 0001209191-21-028565.hdr.sgml : 20210427 20210427161851 ACCESSION NUMBER: 0001209191-21-028565 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210423 FILED AS OF DATE: 20210427 DATE AS OF CHANGE: 20210427 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Demski David M CENTRAL INDEX KEY: 0001555392 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35621 FILM NUMBER: 21859174 MAIL ADDRESS: STREET 1: C/O GLOBUS MEDICAL, INC. STREET 2: 2560 GENERAL ARMISTEAD AVENUE CITY: AUDUBON STATE: PA ZIP: 19403 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GLOBUS MEDICAL INC CENTRAL INDEX KEY: 0001237831 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 043744954 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2560 GENERAL ARMISTEAD AVENUE CITY: AUDUBON STATE: PA ZIP: 19403 BUSINESS PHONE: 610-930-1800 MAIL ADDRESS: STREET 1: 2560 GENERAL ARMISTEAD AVENUE CITY: AUDUBON STATE: PA ZIP: 19403 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-04-23 0 0001237831 GLOBUS MEDICAL INC GMED 0001555392 Demski David M VALLEY FORGE BUSINESS CENTER 2560 GENERAL ARMISTEAD AVENUE AUDUBON PA 19403 1 1 0 0 President, CEO Class A Common Stock 2021-04-23 4 M 0 21875 43.77 A 21875 D Class A Common Stock 2021-04-23 4 M 0 21875 43.58 A 43750 D Class A Common Stock 2021-04-23 4 M 0 22821 29.31 A 66571 D Class A Common Stock 2021-04-23 4 M 0 54688 53.27 A 121259 D Class A Common Stock 2021-04-23 4 S 0 121259 71.59 D 0 D Class A Common Stock 2021-04-26 4 M 0 78334 26.27 A 78334 D Class A Common Stock 2021-04-26 4 M 0 65929 29.31 A 144263 D Class A Common Stock 2021-04-26 4 S 0 144263 71.50 D 0 D Stock Option (Right to Buy Class A Common Stock) 43.77 2021-04-23 4 M 0 21875 0.00 D 2028-01-22 Class A Common Stock 21875 28125 D Stock Option (Right to Buy Class A Common Stock) 43.58 2021-04-23 4 M 0 21875 0.00 D 2029-01-22 Class A Common Stock 21875 65625 D Stock Option (Right to Buy Class A Common Stock) 29.31 2021-04-23 4 M 0 22821 0.00 D 2027-08-28 Class A Common Stock 22821 97179 D Stock Option (Right to Buy Class A Common Stock) 53.27 2021-04-23 4 M 0 54688 0.00 D 2030-01-22 Class A Common Stock 54688 120312 D Stock Option (Right to Buy Class A Common Stock) 26.27 2021-04-26 4 M 0 78334 0.00 D 2027-01-30 Class A Common Stock 78334 0 D Stock Option (Right to Buy Class A Common Stock) 29.31 2021-04-26 4 M 0 65929 0.00 D 2027-08-28 Class A Common Stock 65929 31250 D This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.50 to $71.90, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.50 to $71.53, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. These options were granted on January 22, 2018, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2019, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. These options were granted on January 22, 2019, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2020, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. These options were granted on August 28, 2017, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on August 28, 2018, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. These options were granted on January 22, 2020, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2021, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. These options were granted on January 30, 2017, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2018, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. /s/ Kelly G. Huller, Attorney-in-Fact 2021-04-27